How to appeal a Cigna severe acne denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Cigna-specific note: Sold its Medicaid Advantage book to HCSC in 2023. Express Scripts (PBM) is Cigna-owned. Frequent class-action litigation around mental health parity.

What Cigna's policy requires for severe acne

Cited policy: Cigna / Express Scripts Coverage Policy — Hormonal Acne Therapy (Spironolactone / COC)

COC FDA-approved for acne (Yaz / Beyaz / Estrostep / Ortho Tri-Cyclen) — first-line. Spironolactone NOT FDA-approved for acne — covered with documented COC contraindication or failure. Quantity limit 200 mg/day spironolactone.

How Cigna denies severe acne — and how to counter it

Where Cigna pushes back: 1) Try generic COC first; 2) Spironolactone not FDA-approved for acne; 3) Off-label use.

Counter-arguments that hold up: AAD 2024 Strength A recommendation for spironolactone in adult female acne (Reynolds J Am Acad Dermatol 2024). Document COC contraindication: migraine with aura (ACOG MEC Category 4), smoker >35, prior VTE, breast cancer history. SAFA trial (Santer BMJ 2023;381:e074349) supports spironolactone efficacy. Garg J Am Acad Dermatol 2021 — no hyperkalemia monitoring needed in healthy young women.

What Cigna typically denies for severe acne

Across Cigna's commercial and Medicare books, denials cluster around a small number of patterns. For severe acne, expect:

• Mental health parity violations
• Step therapy
• Specialty drug prior auth
• OON balance billing disputes

Treatments most often denied in this category

These are the severe acne treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Isotretinoin (generic)
• Absorica LD
• Doxycycline
• Minocycline / Solodyn
• Seysara
• Aklief

How to submit the appeal to Cigna

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Cigna cited in the denial.
3. File the appeal through Cigna's portal (members: https://my.cigna.com ; providers: https://cignaforhcp.cigna.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In CT, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Cigna's prior-authorization criteria by drug: Cigna PA criteria on ApprovalHelp.